Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Exagen Inc.

    NASDAQ: XGN · Real-Time Price · USD
    7.52
    0.40 (5.62%)
    At close: Jun 16, 2025, 3:59 PM
    7.20
    -4.26%
    Pre-market: Jun 17, 2025, 07:10 AM EDT

    Exagen Statistics

    Share Statistics

    Exagen has 21.85M shares outstanding. The number of shares has increased by 3.02% in one year.

    Shares Outstanding

    n/a
    		 21.85M

    Shares Change (YoY)

    n/a
    		 3.02%

    Shares Change (QoQ)

    n/a
    		 1.48%

    Owned by Institutions (%)

    n/a
    		 33.49%

    Shares Floating

    n/a
    		 11.2M

    Failed to Deliver (FTD) Shares

    n/a
    		 232

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 177.77K, so 0.81% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 177.77K

    Short % of Shares Out

    n/a
    		 0.81%

    Short % of Float

    n/a
    		 1%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -4.94 and the forward PE ratio is -27.54. Exagen's PEG ratio is 0.13.

    PE Ratio

    n/a
    		 -4.94

    Forward PE

    n/a
    		 -27.54

    PS Ratio

    n/a
    		 1.34

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 7.82

    P/FCF Ratio

    n/a
    		 -5.41

    PEG Ratio

    n/a
    		 0.13
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Exagen.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.7, with a Debt / Equity ratio of 2.41.

    Current Ratio

    n/a
    		 2.7

    Quick Ratio

    n/a
    		 2.7

    Debt / Equity

    n/a
    		 2.41

    Debt / EBITDA

    n/a
    		 -2.06

    Debt / FCF

    n/a
    		 -1.67

    Interest Coverage

    n/a
    		 -6.1

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $266,224.88

    Profits Per Employee

    n/a
    		 $-72,320.57

    Employee Count

    n/a
    		 209

    Asset Turnover

    n/a
    		 1.25

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 12K

    Effective Tax Rate

    n/a
    		 -0.08%

    Stock Price Statistics

    The stock price has increased by 268.63% in the last 52 weeks. The beta is 1.6, so Exagen's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.6

    52-Week Price Change

    n/a
    		 268.63%

    50-Day Moving Average

    n/a
    		 6

    200-Day Moving Average

    n/a
    		 4.19

    Relative Strength Index (RSI)

    n/a
    		 63.67

    Average Volume (20 Days)

    n/a
    		 215,392

    Income Statement

    In the last 12 months, Exagen had revenue of 55.64M and earned -15.12M in profits. Earnings per share was -0.83.

    Revenue

    n/a
    		 55.64M

    Gross Profit

    n/a
    		 33.11M

    Operating Income

    n/a
    		 -13.64M

    Net Income

    n/a
    		 -15.12M

    EBITDA

    n/a
    		 -11.14M

    EBIT

    n/a
    		 -12.87M

    Earnings Per Share (EPS)

    n/a
    		 -0.83
    Full Income Statement

    Balance Sheet

    The company has 22.04M in cash and 23M in debt, giving a net cash position of -969K.

    Cash & Cash Equivalents

    n/a
    		 22.04M

    Total Debt

    n/a
    		 23M

    Net Cash

    n/a
    		 -969K

    Retained Earnings

    n/a
    		 -294.33M

    Total Assets

    n/a
    		 40.29M

    Working Capital

    n/a
    		 18.51M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -13.28M and capital expenditures -515K, giving a free cash flow of -13.79M.

    Operating Cash Flow

    n/a
    		 -13.28M

    Capital Expenditures

    n/a
    		 -515K

    Free Cash Flow

    n/a
    		 -13.79M

    FCF Per Share

    n/a
    		 -0.76
    Full Cash Flow Statement

    Margins

    Gross margin is 59.51%, with operating and profit margins of -24.51% and -27.17%.

    Gross Margin

    n/a
    		 59.51%

    Operating Margin

    n/a
    		 -24.51%

    Pretax Margin

    n/a
    		 -27.14%

    Profit Margin

    n/a
    		 -27.17%

    EBITDA Margin

    n/a
    		 -20.03%

    EBIT Margin

    n/a
    		 -24.51%

    FCF Margin

    n/a
    		 -24.79%

    Dividends & Yields

    XGN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for XGN is $7.5, which is -0.3% lower than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $7.5

    Price Target Difference

    n/a
    		 -0.3%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -6.8

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist